A notable advancement in blood sugar treatment is emerging with the approval of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, and https://haimaujdb449242.howeweb.com/41364399/groundbreaking-development-tirzepatide-strength-for-blood-sugar-control